Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BOSTON SCIENTIFIC CORP Director's Dealing 2020

Jul 9, 2020

29821_dirs_2020-07-06_65d4ec30-1db8-4d2a-8c56-018d86e015ab.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BOSTON SCIENTIFIC CORP (BSX)
CIK: 0000885725
Period of Report: 2020-07-01

Reporting Person: Monson Jonathan (VP, Corp Controller and CAO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2020-07-01 Common Stock M 728.0000 $0.0000 Acquired 34601.0000 Direct
2020-07-01 Common Stock F 221.0000 $35.2800 Disposed 34380.0000 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-01 Deferred Stock Units $ M 728.0000 Disposed 2023-07-01 Common Stock (728.0000) Direct

Footnotes

F1: Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.

F2: Shares of common stock will be issued to the reporting person in four equal annual installments beginning on July 1, 2020, the first anniversary of the date of grant.